Dronedarone and the incidence of stroke in patients with paroxysmal or persistent atrial fibrillation: A systematic review and meta-analysis of randomized trials

American Journal of Cardiovascular Drugs

Volumn 11, Issue 6, 2011, Pages 395-400

  Dagres, Nikolaos ^a   Varounis, Christos ^a   Iliodromitis, Efstathios K ^a   Lekakis, John P ^a   Rallidis, Loukianos S ^a   Anastasiou Nana, Maria ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Atrial fibrillation; Class III antiarrhythmics; Dronedarone; Meta analysis; Paroxysmal atrial fibrillation; Stroke; Transient ischaemic attacks

Indexed keywords

DRONEDARONE;

ARTICLE; CARDIAC PATIENT; CARDIOVERSION; DIABETES MELLITUS; EMBOLISM; EVALUATION AND FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; STROKE; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; TREATMENT RESPONSE;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; MODELS, STATISTICAL; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 83055178360     PISSN: 11753277     EISSN: 1179187X     Source Type: Journal    
DOI: 10.2165/11594200-000000000-00000     Document Type: Article

References (10)

1. Hannon N, Sheehan O, Kelly L, et al. Stroke associated with atrial fibrillation: Incidence and early outcomes in the north Dublin population stroke study. Cerebrovasc Dis 2010; 29: 43-9
2. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-429
3. Connolly SJ, Crijns HJ, Torp-Pedersen C, et al. Analysis of stroke in ATHENA: A placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/ atrial flutter. Circulation 2009; 120: 1174-80
4. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol 2009; 62: 1006-12
5. The Cochrane Collaboration. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. Julian PT Higgins, Sally Green, editors. Chapter 8 [online]. Available from URL: www.cochranehandbook. Org
6. Touboul P, Brugada J, Capucci A, et al. Dronedarone for prevention of atrial fibrillation: A dose-ranging study. Eur Heart J 2003; 24: 1481-7 (Pubitemid 37010577)
7. Singh BN, Connolly SJ, Crijns HJ, et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007; 357: 987-99 (Pubitemid 47367078)
8. Hohnloser SH, Crijns HJ, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009; 360: 668-78
9. Davy JM, Herold M, Hoglund C, et al. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 2008; 156: 527.e1-9
10. Deaths doubled with dronedarone in PALLAS: FDA and EMA updates [online]. Available from URL: http://www.theheart.org/article/1255799/ print.do [Accessed 2011 Aug 2]